Obesity and related metabolic disorders have become a global epidemic. Here, authors reveal that arginase 1 drives hepatic lipid production via a non-enzymatic interaction with ERK2, offering a promising therapeutic target for metabolic diseases.
- Mingyang Shao
- Xiaoyue Cao
- Yujun Shi